XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock And Surplus
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income
Beginning balance (in shares) at May. 28, 2023   121,100    
Beginning balance at May. 28, 2023 $ 2,201.5 $ 2,230.8 $ (32.5) $ 3.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 719.5   719.5  
Other comprehensive income 26.5     26.5
Dividends declared (475.5)   (475.5)  
Stock option exercises (in shares)   300    
Stock option exercises 28.3 $ 28.3    
Stock-based compensation 31.0 $ 31.0    
Repurchases of common stock (in shares)   (2,300)    
Repurchases of common stock (356.6) $ (43.5) (313.1)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   300    
Issuance of stock under Employee Stock Purchase Plan and other plans 8.7 $ 8.7    
Other (2.5) $ (2.5)    
Ending balance (in shares) at Feb. 25, 2024   119,400    
Ending balance at Feb. 25, 2024 2,180.9 $ 2,252.8 (101.6) 29.7
Beginning balance (in shares) at Nov. 26, 2023   119,500    
Beginning balance at Nov. 26, 2023 2,039.7 $ 2,240.8 (228.5) 27.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 312.9   312.9  
Other comprehensive income 2.3     2.3
Dividends declared (157.3)   (157.3)  
Stock option exercises (in shares)   100    
Stock option exercises 8.1 $ 8.1    
Stock-based compensation 4.9 $ 4.9    
Repurchases of common stock (in shares)   (200)    
Repurchases of common stock (32.7) $ (3.9) (28.8)  
Issuance of stock under Employee Stock Purchase Plan and other plans 3.0 3.0    
Other 0.0 $ (0.1) 0.1  
Ending balance (in shares) at Feb. 25, 2024   119,400    
Ending balance at Feb. 25, 2024 2,180.9 $ 2,252.8 (101.6) 29.7
Beginning balance (in shares) at May. 26, 2024   118,900    
Beginning balance at May. 26, 2024 2,242.5 $ 2,252.4 (35.5) 25.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 745.8   745.8  
Other comprehensive income 7.5     7.5
Dividends declared $ (497.8)   (497.8)  
Stock option exercises (in shares) 350 300    
Stock option exercises $ 29.4 $ 29.4    
Stock-based compensation 35.9 $ 35.9    
Repurchases of common stock (in shares)   (2,400)    
Repurchases of common stock (367.2) $ (46.3) (320.9)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   300    
Issuance of stock under Employee Stock Purchase Plan and other plans 9.5 $ 9.5    
Other (2.6) $ (2.6)    
Ending balance (in shares) at Feb. 23, 2025   117,100    
Ending balance at Feb. 23, 2025 2,203.0 $ 2,278.3 (108.4) 33.1
Beginning balance (in shares) at Nov. 24, 2024   117,200    
Beginning balance at Nov. 24, 2024 2,070.9 $ 2,261.0 (218.9) 28.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 323.4   323.4  
Other comprehensive income 4.3     4.3
Dividends declared (165.6)   (165.6)  
Stock option exercises (in shares)   100    
Stock option exercises 13.9 $ 13.9    
Stock-based compensation 6.0 $ 6.0    
Repurchases of common stock (in shares)   (300)    
Repurchases of common stock (53.0) $ (5.7) (47.3)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   100    
Issuance of stock under Employee Stock Purchase Plan and other plans 3.2 $ 3.2    
Other (0.1) $ (0.1)    
Ending balance (in shares) at Feb. 23, 2025   117,100    
Ending balance at Feb. 23, 2025 $ 2,203.0 $ 2,278.3 $ (108.4) $ 33.1